NYSE:ALB - Albemarle Stock Price, Forecast & News

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Tuesday, October 29th. Stockholders of record on Friday, December 13th will be paid a dividend of $0.368 per share on Thursday, January 2nd. This represents a $1.47 annualized dividend and a dividend yield of 1.82%. The ex-dividend date is Thursday, December 12th. This is an increase from Albemarle's previous quarterly dividend of $0.37. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings data on Wednesday, November, 6th. The specialty chemicals company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.49 by $0.04. The specialty chemicals company had revenue of $879.70 million for the quarter, compared to analyst estimates of $883.67 million. Albemarle had a net margin of 16.27% and a return on equity of 15.94%. The firm's revenue for the quarter was up 13.1% compared to the same quarter last year. During the same period last year, the firm posted $1.31 earnings per share. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for Albemarle.

Albemarle issued an update on its FY 2024 Pre-Market earnings guidance on Thursday, December, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $4.4-5 billion.

22 brokers have issued 1 year price objectives for Albemarle's shares. Their forecasts range from $39.50 to $128.00. On average, they anticipate Albemarle's share price to reach $79.40 in the next year. This suggests that the stock has a possible downside of 1.8%. View Analyst Price Targets for Albemarle.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 4 sell ratings, 8 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

Media headlines about ALB stock have trended somewhat negative on Sunday, InfoTrie reports. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a news impact score of -1.7 on InfoTrie's scale. They also assigned news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Albemarle.

Some companies that are related to Albemarle include Ecolab (ECL), Sherwin-Williams (SHW), Celanese (CE), International Flavors & Fragrances (IFF), RPM International (RPM), NewMarket (NEU), W. R. Grace & Co (GRA), Ashland Global (ASH), Balchem (BCPC), Quaker Chemical (KWR), PolyOne (POL), Sensient Technologies (SXT), Innospec (IOSP), HB Fuller (FUL) and Stepan (SCL).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), Wheaton Precious Metals (WPM), Rogers Communications (RCI), Open Text (OTEX) and Valeant Pharmaceuticals Intl (VRX).

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Commerzbank Aktiengesellschaft FI (0.34%), Hahn Capital Management LLC (0.18%), OLD National Bancorp IN (0.08%), Tocqueville Asset Management L.P. (0.05%), State of Alaska Department of Revenue (0.05%) and Kempner Capital Management Inc. (0.03%). Company insiders that own Albemarle stock include Deeanne J Marlow, Eric Norris, Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including IFP Advisors Inc, Hahn Capital Management LLC, SFE Investment Counsel, AE Wealth Management LLC, State of Alaska Department of Revenue, B & T Capital Management DBA Alpha Capital Management, Zeke Capital Advisors LLC and Bangor Savings Bank. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold, Luther C Iv Kissam and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was bought by a variety of institutional investors in the last quarter, including Deane Retirement Strategies Inc., Tocqueville Asset Management L.P., Kempner Capital Management Inc., Red Spruce Capital LLC, Town & Country Bank & Trust CO dba First Bankers Trust CO, Moseley Investment Management Inc., Commerzbank Aktiengesellschaft FI and Ridgewood Investments LLC. Company insiders that have bought Albemarle stock in the last two years include Deeanne J Marlow and Eric Norris. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $80.90.

Albemarle has a market capitalization of $8.58 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.View Additional Information About Albemarle.

The official website for Albemarle is http://www.albemarle.com/.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]